In primary hyperparathyroidism, which radiographic bone changes are classic?

Prepare for the Endocrine Disorder Test. Engage with multiple choice questions with hints and explanations, ensuring a thorough understanding of endocrine system concepts. Excel in your exam with confidence!

Multiple Choice

In primary hyperparathyroidism, which radiographic bone changes are classic?

Explanation:
In primary hyperparathyroidism, excess parathyroid hormone drives osteoclast-mediated bone resorption, leading to distinctive radiographic changes. The classic pattern includes subperiosteal bone resorption, most evident on the radial aspects of the middle phalanges, and brown tumors (osteitis fibrosa cystica) as focal, lytic bone lesions from accelerated turnover. Together, these findings strongly point to this condition on imaging. Generalized bone loss can occur, but the combination of subperiosteal erosions and brown tumors is what makes the radiographic picture classic. Other options don’t fit as well: osteoporosis without resorption lacks the characteristic subperiosteal changes; osteophytes arise from degenerative joint disease; widening of growth plates is seen in rickets or scurvy rather than primary hyperparathyroidism.

In primary hyperparathyroidism, excess parathyroid hormone drives osteoclast-mediated bone resorption, leading to distinctive radiographic changes. The classic pattern includes subperiosteal bone resorption, most evident on the radial aspects of the middle phalanges, and brown tumors (osteitis fibrosa cystica) as focal, lytic bone lesions from accelerated turnover. Together, these findings strongly point to this condition on imaging. Generalized bone loss can occur, but the combination of subperiosteal erosions and brown tumors is what makes the radiographic picture classic. Other options don’t fit as well: osteoporosis without resorption lacks the characteristic subperiosteal changes; osteophytes arise from degenerative joint disease; widening of growth plates is seen in rickets or scurvy rather than primary hyperparathyroidism.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy